Health Care & Life Sciences » Pharmaceuticals | Flexion Therapeutics Inc.

Flexion Therapeutics Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
355.00
22,524
Cost of Goods Sold (COGS) incl. D&A
79.80
120.30
238.20
1,151.00
2,012.00
7,336
Gross Income
79.80
120.30
238.20
1,151.00
1,657.00
15,188
SG&A Expense
17,685.40
26,866.90
45,824.90
68,629.30
128,024.00
174,390
EBIT
17,765.20
26,987.30
46,063.10
69,780.30
129,681.00
159,202
Non Operating Income/Expense
206.60
403.70
927.50
1,887.10
250.00
688
Interest Expense
448.90
401.40
571.00
1,747.20
11,268.00
15,712
Pretax Income
18,186.70
27,313.70
46,315.50
71,894.00
137,481.00
169,659
Consolidated Net Income
18,186.70
27,313.70
46,315.50
71,894.00
137,481.00
169,659
Net Income
18,186.70
27,313.70
46,315.50
71,894.00
137,481.00
169,659
Net Income After Extraordinaries
18,186.70
27,313.70
46,315.50
71,894.00
137,481.00
169,659
Net Income Available to Common
18,186.70
27,313.70
46,315.50
71,894.00
137,481.00
169,659
EPS (Basic)
1.17
1.97
2.15
2.84
4.16
4.49
Basic Shares Outstanding
15,496.10
13,894.00
21,497.10
25,296.50
33,027.00
37,751
EPS (Diluted)
1.17
1.97
2.15
2.84
4.16
4.49
Diluted Shares Outstanding
15,496.10
13,894.00
21,497.10
25,296.50
33,027.00
37,751
EBITDA
17,685.40
26,866.90
45,824.90
68,629.30
127,673.00
157,488
Non-Operating Interest Income
234.00
478.70
1,246.10
1,520.70
3,718.00
4,567

About Flexion Therapeutics

View Profile
Address
10 Mall Road
Burlington Massachusetts 01803
United States
Employees -
Website http://www.flexiontherapeutics.com
Updated 07/08/2019
Flexion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. The firm specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand.